Maravai Lifesciences Holdings (MRVI) Current Leases (2023 - 2025)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Current Leases of $876000.0 in Q2 2025, up 5.04% quarter-over-quarter from $834000.0 in Q1 2025, and up 23.38% on a YoY basis from $710000.0 in Q2 2024.
Maravai Lifesciences Holdings (MRVI) Current Leases (2023 - 2025) Analysis & Trends
Maravai Lifesciences Holdings' Current Leases history runs 3 years deep, the most recent figure standing at $876000.0 for Q2 2025.
- In Q2 2025, Current Leases rose 23.38% year-over-year to $876000.0; the TTM figure through Jun 2025 stood at $876000.0 (up 23.38% YoY), while the FY2024 annual figure was $792000.0, up 25.12% from the prior year.
- Current Leases was $876000.0 for Q2 2025 at Maravai Lifesciences Holdings, up from $834000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $876000.0 in Q2 2025 to a low of $300000.0 in Q1 2023.
- Historically, Current Leases has averaged $672300.0 across 3 years, with a median of $691000.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Current Leases surged 124.0% in 2024, then rose 23.38% in 2025.
- A 3-year view of Current Leases shows it stood at $633000.0 in 2023, then grew by 25.12% to $792000.0 in 2024, then climbed by 10.61% to $876000.0 in 2025.
- The last three Current Leases figures came in at $876000.0 (Q2 2025), $834000.0 (Q1 2025), and $792000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 737.25 Mn | 728.85 Mn | 33.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 876,000.00 |
| Mar 31, 2025 | 834,000.00 |
| Dec 31, 2024 | 792,000.00 |
| Sep 30, 2024 | 750,000.00 |
| Jun 30, 2024 | 710,000.00 |
| Mar 31, 2024 | 672,000.00 |
| Dec 31, 2023 | 633,000.00 |
| Sep 30, 2023 | 596,000.00 |
| Jun 30, 2023 | 560,000.00 |
| Mar 31, 2023 | 300,000.00 |